Addressing the challenges of vaccine formulation - CP22
A complete vaccines brochure covering our offering across the platforms.
Brochure (English)
Language: English
Format: PDF
File size: 12.0 MB
Products
Featured
Super Refined™ Polysorbate 80
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary...
Featured
Super Refined™ Polysorbate 20
Super Refining removes impurities, preventing adverse interactions with APIs and enhancing the stability of pharmaceutical formulations. Super Refined Polysorbates offer the complete solution when...
Featured
Alhydrogel™
One of the most widely used vaccine adjuvants, Alhydrogel is an aluminium-based adjuvant used in clinically-approved vaccines that can elicit effective Th2 immune responses.
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=A29CEF82F5BE8078AFF6628F0576AD4019C138999FEC74AA)
Featured
Adju-Phos™
Well-established as a common component in a variety of vaccines, Adju-Phos is an aluminium-based adjuvant that induces strong Th2 immune responses.
Featured
Quil-A™
A versatile immunostimulatory saponin that’s widely used as a potent veterinary adjuvant, Quil-A can work against both intra- and extra-cellular pathogens, stimulating innate and Th-mediated adaptive...
Featured
QS 21
*sample can be ordered for investigational use only* A powerful immunostimulatory saponin that acts as a potent vaccine adjuvant, QS 21 can stimulate both cell-mediated (Th1) and humoral (Th2)...
Featured
AlhydroVet™
AlhydroVet is an aluminium hydroxide gel product specifically manufactured for use as an adjuvant in veterinary vaccines.
Featured
Cholesterol (plant, parenteral)
Through the Avanti lipid portfolio, Croda Pharma supplies pure, parenteral-grade plant cholesterol that meets USP-NF, EP (2397), and JP pharmaceutical specifications and is ready to ship worldwide.
Featured
3D(6-acyl)-PHAD™
Immunostimulatory and highly purified, 3D(6-acyl)-PHAD activates TLR4 to induce proinflammatory cytokines and T-cells.
Featured
CAF01®
Part of our new generation of adjuvants, CAF01 is a liposomal adjuvant formulation that offers excellent long-term stability and drives both humoral and cellular immune responses.
Featured
CAF09b®
A novel liposomal adjuvant used in cancer immunotherapy trials, CAF09b has the capacity to facilitate the production of CD8+ T-cells.
Featured
PHAD™
Versatile and effective, PHAD acts as a TLR4 agonist to activate proinflammatory cytokines and antigen-specific effector cells.